3^rd International Conference on Hematology & Blood Disorders November 02-04, 2015 Atlanta, USA

OMICS International is overwhelmed to announce the commencement of its 6^th consecutive Hematology conference, "6th International Conference on Hematology &Lymph” during November 14-16, 2016 at San Francisco , USA. The upcoming conference will be organized around the theme “Evaluating the information on the foremost & provokes in hematology”.

Hematology-2016 is a global platform to discuss and learn about Blood components, Blood Disorders, Hemophilia, Blood malignance, Blood Oncology, Stem cell transplantation, Blood transfusion, Diagnosis & therapies of  diseases, Development of the drugs, Lymphatic system, Antigen & Antibody reactions and Haematology researches.

Blood- Components and Functions:

The blood contains of the erythrocytes, leukocytes, Red blood cells, White blood cells, Complete blood count, plasma cells, and platelets. Sometimes when the blood of two people is mixed together, it clumps or forms visible islands in the liquid plasma--the red cells become attached to one another this is agglutination which results in formation of fibrins. Erythrocytes are also known as red blood cells which carry oxygen to the body and collect carbon dioxide from the body by the use of haemoglobin and its life span of 120 days. along the side the leucocytes helps in protecting the healthy cells because the white blood cells (leucocytes) act as the defending cells in protecting the immune system from the foreign cells

Related conference:

5^th world congress on Hemophilia at UK  from June 06-08, 2016. 4^th International conference on Blood malignance and Treatment  at  UAE from April 18-20, 2016. Global Summit on Melanoma and Carcinoma at Australia from July 14-15, 2016. Cancer Diagnostics Conference & Expo  Rome, Italy from June 13-15, 2016. 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics, at USA from September 26-28, 2016. Society for Haematology and stem cells 44th annual scientific meeting 2015, at  Japan from September 17-19, 2015. Hellenic Society of Haematology  26^th  National Congress 2015  at Athens from November 12^th –14^th, 2015. British Society  for Haemostasis and Thrombosis Annual Meeting 2015 at UK from November 12^th -14^th, 2015. Society for Immunotherapy of Cancer's Advances in Cancer Immunotherapy 2015 at USA on December 4^th 2015. American Society of Haematology 57th Annual Meeting 2015 at USA from December 5^th – 8^th, 2015. Scripps’ 36th Annual Conference Clinical Haematology & Oncology 2016 at USA from February 13^th – 16^th, 2016.

Haematologic Malignancies:

Hematology oncology is the most important part of Haematology research, a major part of blood based researches is carried out in this field. Lymphatic leukemic which effect the white blood cells (w.b.c) they are closely related to the lymphomas and some of them are unitary diseases which related to the adult T cells leukaemia these come under the lymph proliferative disorders. The cancer which originates from white blood cells are called as lymphoma and this disorder is mainly seen in Hodgkin lymphoma these diseases are treated by radiation and chemotherapy, or hematopoietic stem cell transplantation. The cancer which starts with in the cell is called as Non Hodgkin lymphocytes and these lymphocytes are of lymph nodes. The bone marrow which develops too many white blood cells leads to multiple myeloma. The further details on malignance are been discussed in Haematology oncology conference.    

Related conferences:

2nd International Conference on Prostate Cancer and Treatment at USA May 05-07, 2016. 6th World Congress on Cancer Therapy at USA from December 01-03, 2016. Experts Meeting on Gynaecologic Oncology  at USA May 19-21, 2016. International Conference on Pancreatic and Colorectal Cancer at USA from March 29-30, 2016. 10th Global Annual Oncologists  Meeting at Germany from July 11-13,2016.  2th European Congress on Hematologic Malignancies at Spain from February 2016. 17th Annual John Goldman Conference on Chronic Myeloid Leukaemia at Portugal from October 01-04,2015. International Conference on Aging and Haematological Malignancies: Biology and Therapy at Greece from March 11 -13, 2016. 3rd International Conference on  Multiple Myeloma at Italy from October 07- 09, 2016.

Hemato-immunology & Stem Cell Research:

Blood groups are of ABO type and but at present the Rh blood grouping of 50 well defined  antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis  lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer to. The disorder of immune system leading to hypersensitivity is called as Clinical Immunology and the abnormal growth of an infection are known as Inflammation and the arise of an abnormal immune response to the body or an immune suppression are known as Auto immune disorder.

Related Conferences:

2nd International Congress on Neuroimmunology and Therapeutics at USA from March 31-April 02, 2016. 4th International Conference and Exhibition on Immunology at USA from September 28-30, 2015. International Conference on Cancer Immunology and Immunotherapy   at Australia from July 28^th -30^th ,2016. 6th World Congress on Cell & Stem Cell Research at USA from February 29^th – March 02^nd, 2016. 5th International Conference on Tissue Science and Regenerative Medicine at Germany, from September 12-14, 2016. 20th Training Course on Haemopoietic  Stem Cell Transplantation at Hungary from May 11 - 14, 2016. . 5^th International Conference on  Myelodysplastic Syndromes  at Portugal from April 14 -16, 2016. 7th International Conference on Myeloproliferative Neoplasms at Portugal from October 27 - 29, 2016. 2015 World Stem Cell Summit & REGMED Capital Conference at USA from December 10-12, 2015. Australasian Society for Stem Cell Research (ASSCR) 8th Annual Meeting at Australia from November 8-10, 2015.

Blood Transplantation, Thrombosis and Hemostasis:

The umbilical cord is a conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies the fetus with  nutrient-rich blood from the placenta The hematopoietic bone marrow transplant, the HSC are removed from a large bone of the donor, typically the pelvis, through a large need let that reaches the center of the bone. Acute myeloid leukaemia is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells and the Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. The Hemostatic is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing.

Related Conferences:

International Conference and Exhibition on Transplantation Research & Techniques at USA from March 28-29, 2016. 5th International Conference and Expo on Cosmetology, Trichology & Aesthetic Practices at UAE from April 25-27, 2016. International Conference and Exhibition on Plastic and Reconstructive Surgery at USA from October 03-05, 2016. 5^th world congress on Hemophilia at UK  from June 06-08, 2016. 4^th International conference on Blood malignance and Treatment at UAE from April 18-20, 2016. 6th International Eurasian Haematology  Congress at Turkey  from October 14^th -18^th 2015, Japanese Society of Haematology  77th Annual Meeting at Japan from October 16^th- 18^th  2015. Portuguese Society of Haematology Annual Meeting at Portugal from November 12- 14,2015. Hellenic Society of Haematology 26th National Congress at Greece from November 12-14, 2015.  American Society of Hematology 57th Annual Meeting at United States from November 16-18 2015. 10th Dutch Haematology Congress at Netherlands from January 20-22, 2016.

Diagnosis, Treatment and Management of Blood Disorders:

 Palliative care is a multidisciplinary approach to specialised medical care for people with serious illnesses The spleen, similar in structure to a large lymph node, acts as a blood filter. Anticoagulants (antithrombics) are a class of drugs that work to prevent the coagulation (clotting) of blood. Some anticoagulants are used in medical equipment, such as test  tubes ,blood transfusion bags, and renal dialysis equipment. An  vena cava filter  is a type of vascular filter, a medical device that is implanted by interventional radiologists or vascular surgeons into the inferior vena cava to presumably prevent life-threatening pulmonary emboli is therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells.

Related conferences:

Specialists Meeting on Ear, Nose and Throat Disorders at Spain from November 03-05, 2016. International Conference on Anaesthesia and Intensive CareTreatment at USA from September 12-14, 2016. 4th International Conference and Exhibition on Surgery at UAE from October 05-07, 2015. International Conference on Hospice & Palliative Care at USA August 25-27, 2016. Blood malignance and Treatment  at  UAE from April 18-20, 2016. IPFA/BCA 2nd Global Symposium on "The Future for Blood and Plasma Donations at USA from September 28-29, 2015. WFH Global Forum On Research and Treatment Products for Bleeding Disorders at Quebec from October 22-23, 2015. European School of Transfusion Medicine residential course learning the best ways for caring for blood donor: the significance of this for safer blood and better European Transfusion Medicine at Italy from December 2-6, 2015. 56th Annual meeting of the Indian Society of Haematology and Blood Transfusion at INDIA in November,2015. EHC Annual Conference 2015 at Serbia from October 2-3, 2015.

Blood Disorders and Blood Oncology:

Hemophilia A is a genetic deficiency in clotting factor VIII, which causes increased bleeding and usually affects males. About 70% of the time it is inherited as an X-linked recessive trait, but around 30% of cases arise from spontaneous mutations. Hemophilia B  is a blood clotting disorder caused by a mutation of the factor IX gene, leading to a deficiency of factor IX. It is the second-most common form of haemophilia, rarer than haemophilia A. It is sometimes called Christmas disease, named after Stephen Christmas, the first patient described with this disease.In addition, the first report of its identification was published in the Christmas edition of the British Medical Journal. Hemophilia C  is a mild form of haemophilia affecting both sexes. However, it predominantly occurs in Jews of Ashkenazi descent. It is the fourth most common coagulation disorder after von Willebrand's disease and haemophilia A and B. In the USA it is thought to affect 1 in 100,000 of the adult population, making it 10% as common as haemophilia A. Idiopathic thrombocytopenic purpura (ITP), also known as immune thrombocytopenia, primary immune thrombocytopenia,primary immune thrombocytopenic purpura or autoimmune thrombocytopenic purpura, is defined as isolated low platelet count (thrombocytopenia) with normal bone marrow and the absence of other causes of thrombocytopenia Von Willebrand diseases is the most common hereditary coagulation abnormality described in humans.

Related  Conferences:

Blood malignance and Treatment  at  UAE from April 18-20, 2016. International Conference on Leukaemia and Bone marrow Transplantation at Turkey from November 10-12, 2016 . Global Summit on Melanoma and Carcinoma at Australia from July 14-15, 2016. International Conference on Pancreatic and Colorectal Cancer at USA from March 29-30, 2016. 11th Asia-Pacific Oncologists Annual Meeting at Malaysia from July 11-13, 2016. 4th International Conference on Immunotherapy in Pediatric Oncology at United States from September 25-26 , 2015. 9th Annual Sickle Cell and Thalassemia Advanced Conference at United Kingdom from October 07^th -210^th, 2015. VI Inter American Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies at Argentina from October 08-09, 2015. Synergy 2015: A Multidisciplinary Approach to Interventional Oncology at United States from November 05-08, 2015. Haematology — Management Issues in Haematological Disorders in Adults at United Kingdom from November 23^rd 2015.

New Drug Development in Haematology:

The development of antibiotic resistance in particular stems from the drugs targeting only specific bacterial molecules. Because the drug is so specific, any mutation in these molecules will interfere with or negate its destructive effect, resulting in antibiotic resistance. Known as Drug delivery Conditions treated with combination therapy include tuberculosis, leprosy, cancer, malaria, and HIV/AIDS. One major benefit of combination therapies is that they reduce development of drug resistance, since a pathogen or tumor is less likely to have resistance to multiple drugs simultaneously. Artemisinin-based monotherapies for malaria are explicitly discouraged to avoid the problem of developing resistance to the newer treatment. Drug Induced Blood Disorders causes of sickle cell anemia,pale skin non steroids anti-inflammatory  drugs which causes ulcers Using drug repositioning, pharmaceutical companies have achieved a number successes, for example Pfizer's Viagra in erectile dysfunction and Celgene's thalidomide in severe erythema nudism leprous.

Related Conferences:

4th International Conference on Translational Medicine at USA from October 26-28, 2015. 2nd Global Summit on Telemedicine & eHealth at Turkey from October 31-November 2, 2016. World Congress on Health & Medical Sociology  at Italy from September 06-07, 2016. International Conference and Exhibition on Nano medicine  and  Nanotechnology in Health Care at Thailand from July 25-27, 2016. 3rd International Conference on Health Informatics and Technology at USA June 27-29, 2016. 6th World Specific Antibody Summit at USA from September 22-24, 2015. 20th World Congress on Advances in Oncology at Greece from October 08-10, 2015.  18^th  International Symposium on Molecular Medicine at Greece from October 08-10, 2015. South Africa Meeting on Translational Cancer Research   at South Africa from October 12-16,2015. Chimeric Antigen Receptor Therapy in Haematology and Oncology: Current Successes and Challenges at United Kingdom from October 19^th -20^th, 2015.

Transfusion Medicine and Haematology research:

Lymphatic diseases this is a type of cancer of the lymphatic system. It can start almost any where in the body. It's believed to be caused by HIV, Epstein-Barr Syndrome, age and family history. Symptoms include weight loss, fever, swollen lymph nodes, night sweats, itchy skin, fatigue, chest pain, coughing and/or trouble swallowing. The lymphatic system is part of the circulatory system, comprising a network of lymphatic vessels that carry a clear fluid called lymph directionally towards the heart. The lymphatic system was first described in the seventeenth century independently by Olaus Rudbeck and Thomas Bartholin. Unlike the cardiovascular system the lymphatic system is not a closed system. The human circulatory system processes an average of 20 litres of blood per day through capillary filtration which removes plasma while leaving the blood cells. Roughly 17 litres of the filtered plasma get reabsorbed directly into the blood vessels, while the remaining 3 litres are left behind in the interstitial fluid. One of the main functions of the lymph system is to provide an accessory return route to the blood for the surplus 3 litres. Lymphatic diseases are of Non-Hodgkin's Lymphoma, Hodgkins.

Related Conferences:

4th International Conference on Translational Medicine at USA from October 26-28, 2015. International Conference on Precision Medicine at USA from November 03-05, 2016. International Conference and Exhibition on Medical Writing and Healthcare Communications at UAE from April 28-29, 2016. Nano medicine  and Nanotechnology in Health Care at Thailand from July 25-27, 2016. 3rd International Conference on Health Informatics and Technology at USA June 27-29, 2016. 6th World Specific Antibody Summit at USA from September 22-24, 2015. 20th World Congress on Advances in Oncology at Greece from October 08-10, 2015. 18th International Symposium on Molecular Medicine at Greece from October 08-10, 2015. South Africa Meeting on  Translational Cancer Research at South Africa from October 12-16, 2015. Chimeric Antigen Receptor  Therapy in Haematology and Oncology  Current Successes and Challenges at United Kingdom from October 19^th -20^th, 2015.

Various Aspects of Haematology:

Pediatric Haematology covers all aspects of pediatrichematology and oncology. It includes immunology, pathology, and pharmacology in relation to blood diseases and cancer in children and shows how basic experimental research can contribute to the understanding of clinical problems. Physicians specialized in hematology are known as hematologists or haematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the hematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various hematological test results and blood clotting test results. In some institutions, hematologists also manage the hematology laboratory. Physicians who work in haematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologists or haematopathologists. Experimental Hematology is another important part of blood based reserach carried out throughout the world.

Related conferences:

5^th world congress on Hemophilia at UK  from June 06-08, 2016. 4^th International conference on Blood malignance and Treatment  at  UAE from April 18-20, 2016. Global Summit on Melanoma and Carcinoma at Australia from July 14-15, 2016. Cancer Diagnostics Conference & Expo  Rome, Italy from June 13-15, 2016. 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics, at USA from September 26-28, 2016. Society for Haematology and stem cells 44th annual scientific meeting 2015, at  Japan from September 17-19, 2015. Hellenic Society of Haematology  26^th  National Congress 2015  at Athens from November 12^th –14^th, 2015. British Society  for Haemostasis and Thrombosis Annual Meeting 2015 at UK from November 12^th -14^th, 2015. Society for Immunotherapy of Cancer's Advances in Cancer Immunotherapy 2015 at USA on December 4^th 2015. American Society of Haematology 57th Annual Meeting 2015 at USA from December 5^th – 8^th, 2015. Scripps’ 36th Annual Conference Clinical Haematology & Oncology 2016 at USA from February 13^th – 16^th, 2016.

Effect of Advanced Technologies on Blood Based Products:

A blood substitute  is a substance used to mimic and fulfill some functions of biological blood. It aims to provide an alternative to blood transfusion, which is transferring blood or blood-based products from one person into another. Thus far, there are no well-accepted oxygen-carrying blood substitutes, which is the typical objective of a red blood cell transfusion; however, there are widely available non-blood volume expanders for cases where only volume restoration is required. These are helping doctors and surgeons avoid the risks of disease transmission and immune suppression, address the chronic blood donor shortage, and address the concerns of Jehovah's Witnesses and others who have religious objections to receiving transfused blood. Pathogen reduction using riboflavin and UV light is a method by which infectious pathogens in blood for transfusion are inactivated by adding riboflavin and irradiating withUV light. This method reduces the infectious levels of disease-causing agents that may be found in donated blood components, while still maintaining good quality blood components for transfusion. This type of approach to increase blood safety is also known as “pathogen inactivation” in the industry.

Related Conferences:

3rd International Conference on Health Informatics and Technology at USA June 27-29, 2016. 2nd International Conference and Exhibition on Molecular Medicine and Diagnostics, at USA from September 26-28, 2016. Nano medicine  and  Nanotechnology in Health Care at Thailand from July 25-27, 2016. 4th International Conference on Translational Medicine at USA from October 26-28, 2015. 2nd Global Summit on Telemedicine & eHealth at Turkey from October 31-November 2, 2016. 6th World Specific Antibody Summit at  USA from September 22-24, 2015. 20th World Congress on Advances in Oncology at Greece from October 08-10, 2015. 18th International Symposium on Molecular Medicine at Greece from October 08-10, 2015. South Africa Meeting on  Translational Cancer Research at South Africa from October 12-16, 2015. Chimeric Antigen Receptor Therapy in Haematology and Oncology: Current Successes and Challenges at United Kingdom from October 19^th -20^th, 2015.

Lymph and Associated Diseases

T cells (thymus cells) and B cells are the major cellular components of the adaptive immune response. T cells are involved in cell-mediated immunity, whereas B cells are primarily responsible for humoral immunity The function of T cells and B cells is to recognize specific “non-self” antigens, during a process known as antigen presentation. Once they have identified an invader, the cells generate specific responses that are tailored to maximally eliminate specific pathogens or pathogen-infected cells. The circulatory system, also called the cardiovascular system, is an organ system that permits blood to circulate and transport nutrients, oxygen, carbon dioxide, hormones, and blood cells to and from the cells in the body to provide nourishment and help in fighting diseases, stabilize temperature and pH, and maintain homeostasis. Lymphatic disease is a class of disorders which directly affect the components of the lymphatic system. The thymus is a specialized primary lymphoid organ of the immune system. Within the thymus, T cells or T lymphocytes mature. T cells are critical to the adaptive immune system, where the body adapts specifically to foreign invaders.

Related Conferences:

4th International Conference and Exhibition on Immunology at USA, from September 28-30, 2015. 2nd International Conference on Innate Immunity at Germany from July 21-22, 2016. International Conference on Autoimmunity at UK from October 13-15, 2016. International Conference on Lupus at USA from October 27-28, 2016. 2nd International Conference and Exhibition on Antibodies at USA from July 14-15, 2016. Molecular Mechanisms in Lymphatic Function & Disease at Italy from March 9-14, 2016. Asia Pacific Lymphology Conference at Australia from May 26^th- 28^th, 2016. 25th World Congress of Lymph ology at USA from August 31^st- September 4^th,2016. World Stem Cell Summit & REGMED Capital Conference at USA from December 10-12, 2015. Australasian Society for Stem Cell Research (ASSCR) 8th Annual Meeting at Australia from November 8-10, 2015.